Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Nivolumab for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for or having failed autologous transplantation: A single-arm, phase II study. Have a read: https://www.m3india.in/contents/journal/nivolumab-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-in-patients-ineligible-2?utm_campaign=unset&utm_medium=share&utm_source=ref_wa